66
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Allergic Rhinitis does not Constitute a Risk Factor for Obstructive Sleep Apnea Syndrome

, , , &
Pages 494-499 | Published online: 08 Jul 2009

References

  • AASM Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667–89.
  • Guilleminauh C, Tilkian A, Dement WC. The sleep apnea syndrome. Am Rev Med 1976; 27: 465–84.
  • Norton PG, Dunn EV. Snoring as a risk factor for diseases: an epidemiologic survey. BMJ 1985; 291: 860–3.
  • Gisalson T, Almquist M, Eriksson G, Tarbe A, Boman G. Prevalence of sleep apnea among Swedish men: an epidemiological study. J Clin Endocrinol 1988; 41: 571–6.
  • Sullivan CE, Issa FG. Pathophysiological mechanisms in obstructive sleep apnea. Sleep 1980; 3: 235–46.
  • Scharf MB, Cohen AP. Diagnostic and treatment im-plications of nasal obstruction in snoring and obstruc-tive sleep apnea. Ann Allergy Asthma Immunol 1998; 81: 279–87.
  • Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol 1997; 99: S757–62.
  • Proctor DF. The upper airways. Nasal physiology and defense of the lungs. Am Rev Respir Dis 1977; 115: 97–129.
  • Zwillich C, Pickett C, Hanson F, Weil J. Disturbed sleep and prolonged apneas during nasal obstruction in normal men. Am Rev Respir Dis 1981; 135: 159–60.
  • Olsen KD, Kern EB, Westbrook PR. Sleep and breath-ing disturbance secondary to nasal obstruction. Otolar-yngol Head Neck Surg 1981; 89: 804–10.
  • Suratt PM, Turner BL, Wilhoit SC. Effect of intranasal obstruction on breathing during sleep. Chest 1986; 90: 324–9.
  • Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids J Allergy Clin Immunol 1998; 101: 633–7.
  • van Aas K, Aberg N, Bachert C, et al. Epidemiology: prevalence of allergic diseases. In: van Moerbeke D, ed. European Allergy White Paper. Brussels, Belgium. UCB Institute of Allergy, 1997.
  • Wiithrich B, Schindler C, Leuenberger P, Ackermann-Liebrich U. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA Study). Int Arch Allergy Immunol 1995; 106: 149–56.
  • Sly RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999; 82: 233–52.
  • van Aas K, Aberg N, Bachert C, et al. Socio-economic costs of allergic diseases. Epidemiology: prevalence of allergic diseases. In: van Moerbeke D, ed. European Allergy White Paper. Brussels, Belgium. UCB Institute of Allergy, 1997.
  • Deutsche Gesellschaft fiir Allergologie und Klinische Immunologie (DGAI). Weissbuch der Allergie in Deutschland 2000, 1st edn. Munich: Urban and Vogel, 2000.
  • McNicholas WT, Tarlo S, Cole P. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 1982; 126: 625–8.
  • Olsen KD, Kern EB. Nasal influences on snoring and obstructive sleep apnea. Mayo Clin Proc 1990; 65: 1095–105.
  • McColley SA, Carroll JL, Curtis S, Loughlin GM, Sampson HA. High prevalences of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 1997; 111: 170–3.
  • American Thoracic Society. Indications and standards for cardiopulmonary sleep studies. Am Rev Respir Dis 1989; 139: 569.
  • Agnew HW, Webb WB, Williams RL. The first night effect: an EEG study of sleep. Psychophysiology 1966; 2: 263–6.
  • Browman CP, Cartwright RD. The first night effect on sleep and dream. Bol Psychiatry 1980; 15: 809–12.
  • Rechtschaffen A, Kales A. A manual of standardized technology, techniques and scoring system for sleep stages of human subjects. Los Angeles, CA: Brain Information Service/Brain Research Institute, UCLA, 1968.
  • Klimek L, Rasp G. Norm values for eosinophil cationic protein in nasal secretions: influence of speci-men collection. Clin Exp Allergy 1999; 29: 367–74.
  • Kramer MF, Ostertag P, Pfrogner E, Rasp G. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polypo-sis. Laryngoscope 2000; 110: 1056–62.
  • Lavie P, Fischel N, Zomer J, Eliaschar I. The effects of partial and complete mechanical occlusion of the nasal passage in sleep structure and breathing in sleep. Acta Otolaryngol 1983; 95: 161–6.
  • Duchna HW, Rasche K, Lambers N, Orth M, Merget R, Schultze WG. Incidence of cutaneous sensitization to environmental allergens in obstructive sleep apnea syndrome. Pneumologie 1997; 51 (Suppl 3): 763–6.
  • Crobach M, Hermans J, Kaptein A, Ridderikhoff J, Mulder J. Nasal smear eosinophilia in the diagnosis of allergic rhinitis and eosinophilic non-allergic rhinitis. Scand J Prim Health Care 1996; 14: 116–21.
  • Jacobs RL, Freedmann PM, Boswell RN. Nonallergic rhinitis with eosinophilia (NARES) syndrome. J Al-lergy Clin Immunol 1981; 61: 253–62.
  • Rubinstein I. Nasal inflammation in patients with ob-structive sleep apnea. Laryngoscope 1985; 105: 175–7.
  • Olopade CO, Christon JA, Zakkar M. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 1997; 111: 1500–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.